(A) Agilent Technologies - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00846U1016
A: Chromatography, Mass Spectrometry, Genomics, Diagnostics, Services
Agilent Technologies, Inc. is a leader in providing application-focused solutions for the life sciences, diagnostics, and applied chemical markets globally. The company excels in analytical instruments, playing a crucial role in pharmaceuticals, biotechnology, and research. Its Life Sciences and Applied Markets segment offers advanced chromatography systems, mass spectrometry instruments, and software solutions that enhance laboratory efficiency and data integration. The Diagnostics and Genomics segment delivers cutting-edge tools for genomics and cell analysis, aiding in medical research and diagnostics. Agilent CrossLab provides comprehensive services, including instrument maintenance and software support, ensuring optimal lab operations. Incorporated in 1999, Agilent is headquartered in Santa Clara, California, and is recognized for its commitment to innovation and customer support.
Over the next three months, Agilent is expected to face a challenging environment. Technically, the stocks last price of $102.48 is below its SMA20 ($110.14) and SMA50 ($122.08), indicating a potential downtrend. The ATR of 4.33 signals higher volatility. Fundamentally, with a P/E of 23.50 and forward P/E of 18.42, the market may anticipate earnings growth. The Market Cap of $29.2 billion underscores its large-cap status. A P/S of 4.47 reflects moderate revenue valuation. While the RoE of 20.89% highlights strong profitability, investors should monitor these metrics closely for potential shifts in market sentiment.
Additional Sources for A Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
A Stock Overview
Market Cap in USD | 30,897m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC Sub-Industry | Life Sciences Tools & Services |
IPO / Inception | 1999-11-18 |
A Stock Ratings
Growth Rating | 12.0 |
Fundamental | 57.5 |
Dividend Rating | 53.5 |
Rel. Strength | -20.1 |
Analysts | 4/5 |
Fair Price Momentum | 89.49 USD |
Fair Price DCF | 85.16 USD |
A Dividends
Dividend Yield 12m | 0.79% |
Yield on Cost 5y | 1.23% |
Annual Growth 5y | 12.10% |
Payout Consistency | 67.2% |
A Growth Ratios
Growth Correlation 3m | -89.3% |
Growth Correlation 12m | -38.9% |
Growth Correlation 5y | 27.4% |
CAGR 5y | 6.70% |
CAGR/Max DD 5y | 0.16 |
Sharpe Ratio 12m | -0.45 |
Alpha | -32.95 |
Beta | 0.844 |
Volatility | 38.97% |
Current Volume | 2093.3k |
Average Volume 20d | 1838.3k |
As of May 09, 2025, the stock is trading at USD 108.70 with a total of 2,093,340 shares traded.
Over the past week, the price has changed by +2.10%, over one month by +9.48%, over three months by -24.19% and over the past year by -23.31%.
Partly, yes. Based on ValueRay Fundamental Analyses, Agilent Technologies (NYSE:A) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 57.51 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of A as of May 2025 is 89.49. This means that A is currently overvalued and has a potential downside of -17.67%.
Agilent Technologies has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy A.
- Strong Buy: 9
- Buy: 2
- Hold: 9
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, A Agilent Technologies will be worth about 99.4 in May 2026. The stock is currently trading at 108.70. This means that the stock has a potential downside of -8.55%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 140.6 | 29.3% |
Analysts Target Price | 140.6 | 29.3% |
ValueRay Target Price | 99.4 | -8.5% |